Drug Trial Radar · NCT01343004
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
Last checked: Nov 20, 2026Latest source record: Mar 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,463
Actual
Start
Apr 2011
Primary completion
Oct 2014
Study completion Oct 2014
Sponsor
- Lead sponsor
- Radius Health, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 27, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether BA058 (abaloparatide), a parathyroid hormone-related peptide, is effective in preventing fractures in postmenopausal women with severe osteoporosis who are at risk of fractures.
Conditions
- Osteoporosis
- Postmenopausal Osteoporosis
Interventions
PlaceboDrug
Placebo 0 mcg subcutaneous daily
BA058 80 mcgDrug
BA058 80 mcg subcutaneous daily
teriparatideDrug
teriparatide 20 mcg subcutaneous daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With New Vertebral Fractures at 18 MonthsTime frame: 18 months
Locations
28 sites in 10 countries. Site status is shown where the registry gives one.
Site not named
Lakewood, Colorado
Site not named
Miami, Florida
Site not named
North Miami, Florida
Site not named
Atlanta, Georgia
Site not named
Bethesda, Maryland
Site not named
Buenos Aires, Argentina
Site not named
Brasília, Brazil
Site not named
Curitiba, Brazil
Site not named
Rio de Janeiro, Brazil
Site not named
São Paulo, Brazil
Site not named
Vitória, Brazil
Site not named
Brno, Czechia
Site not named
Pardubice, Czechia
Site not named
Prague, Czechia
Site not named
Aalborg, Denmark
Site not named
Ballerup Municipality, Denmark
Site not named
Vejle, Denmark
Site not named
Tallinn, Estonia
Site not named
Tartu, Estonia
Site not named
Hong Kong, Hong Kong
Site not named
Vilnius, Lithuania
Site not named
Bialystok, Poland
Site not named
Katowice, Poland
Site not named
Kielce, Poland
Site not named
Lodz, Poland
Site not named
Warsaw, Poland
Site not named
Zgierz, Poland
Site not named
Bucharest, Romania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.